{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import os\n",
    "import spacy\n",
    "import warnings; warnings.simplefilter('ignore')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "task1.csv\n",
      "task10.csv\n",
      "task2.csv\n",
      "task3.csv\n",
      "task4.csv\n",
      "task5.csv\n",
      "task6.csv\n",
      "task7.csv\n",
      "task9.csv\n"
     ]
    }
   ],
   "source": [
    "nlp = spacy.load('en_core_web_lg')\n",
    "DIR = \"csvfiles/tasks/\"\n",
    "\n",
    "for i in os.listdir(DIR):\n",
    "    print(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 119,
   "metadata": {},
   "outputs": [],
   "source": [
    "def show_relevant_articles(task_num, tags):\n",
    "    df = pd.read_csv(DIR + f\"task{task_num}.csv\")\n",
    "    inf = []\n",
    "    sentences = []\n",
    "    \n",
    "    for i, row in df.iterrows():\n",
    "        if len(row[2]) <= 50:\n",
    "            break\n",
    "        akapity = row[2].split('\\n')\n",
    "        a = row[1].split('\\n')\n",
    "        akapity.append(a)\n",
    "        try:\n",
    "            for akapit in akapity:\n",
    "                if len(akapit) <= 500:\n",
    "                    break\n",
    "                tag = nlp(tags)\n",
    "                ak = nlp(akapit.lower())\n",
    "                similarity = tag.similarity(ak)\n",
    "                inf.append([akapit, similarity])\n",
    "        except: pass\n",
    "        sorted_results = sorted(inf, key=lambda x: x[1], reverse=True)[:2]\n",
    "        print(\"----------------------------------------\")\n",
    "        print(row[0].upper())\n",
    "        print(\"----------------------------------------\" + \"\\n\")\n",
    "        for j in sorted_results:\n",
    "            print(j[0] + \"\\n\\n\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "def find_duplic(infos):\n",
    "    df = pd.DataFrame(infos)\n",
    "    df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 120,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "ENVIRONMENTAL CONDITIONS AFFECT EXHALATION OF H3N2 SEASONAL AND VARIANT INFLUENZA VIRUSES AND RESPIRATORY DROPLET TRANSMISSION IN FERRETS\n",
      "----------------------------------------\n",
      "\n",
      "Influenza viruses display distinct seasonal patterns in temperate climates with peak infection rates occurring in the winter months and little to no influenza virus activity detected at other times of the year [1] . However, it is not completely understood why we have \"flu seasons\". The same seasonal trends do not necessarily apply to regions in tropic and subtropic climates where influenza virus activity can be detected year round. Social and health factors such as indoor crowding and seasonal fluctuations in host immunity have been offered as explanations for influenza seasonality, but the lack of direct evidence supporting these theories suggests that the environment may be the most relevant contributor and potential driving force of seasonality [1, 2] . Although seasonal influenza viruses display predictable infection patterns, the four most recent influenza virus pandemics began with newly emerged viruses appearing outside the usual influenza season (1918 Spanish Influenza A H1N1, 1957 -1958 Asian Influenza A H2N2, 1968 Hong Kong Influenza A H3N2, 2009 H1N1) [3, 4] . Emergence of the most recent pandemic virus was preceded by reports of sporadic infections of a swine-origin H1N1 virus in young individuals [4, 5] . During the summers of 2010-2014, reports have emerged in the Midwest region of the U.S. of H3N2 variant influenza virus infections in children with a recent history of exposure to swine [6] [7] [8] [9] [10] . These events highlight the importance of closely monitoring emerging strains of influenza viruses throughout the year and the need for our improved understanding of the effects of environmental conditions like temperature and humidity on influenza virus transmission.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "HOST GENETICS DETERMINE SUSCEPTIBILITY TO AVIAN INFLUENZA INFECTION AND TRANSMISSION DYNAMICS\n",
      "----------------------------------------\n",
      "\n",
      "Influenza viruses display distinct seasonal patterns in temperate climates with peak infection rates occurring in the winter months and little to no influenza virus activity detected at other times of the year [1] . However, it is not completely understood why we have \"flu seasons\". The same seasonal trends do not necessarily apply to regions in tropic and subtropic climates where influenza virus activity can be detected year round. Social and health factors such as indoor crowding and seasonal fluctuations in host immunity have been offered as explanations for influenza seasonality, but the lack of direct evidence supporting these theories suggests that the environment may be the most relevant contributor and potential driving force of seasonality [1, 2] . Although seasonal influenza viruses display predictable infection patterns, the four most recent influenza virus pandemics began with newly emerged viruses appearing outside the usual influenza season (1918 Spanish Influenza A H1N1, 1957 -1958 Asian Influenza A H2N2, 1968 Hong Kong Influenza A H3N2, 2009 H1N1) [3, 4] . Emergence of the most recent pandemic virus was preceded by reports of sporadic infections of a swine-origin H1N1 virus in young individuals [4, 5] . During the summers of 2010-2014, reports have emerged in the Midwest region of the U.S. of H3N2 variant influenza virus infections in children with a recent history of exposure to swine [6] [7] [8] [9] [10] . These events highlight the importance of closely monitoring emerging strains of influenza viruses throughout the year and the need for our improved understanding of the effects of environmental conditions like temperature and humidity on influenza virus transmission.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "ENVIRONMENTAL FACTORS AFFECTING THE TRANSMISSION OF RESPIRATORY VIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "Viral respiratory tract infections are both ubiquitous and burdensome, accounting for many millions of lost school-and workdays and millions more physician visits each year [1] . Although there are similarities in the clinical syndromes caused by the many viruses capable of infecting and causing disease in the human respiratory tract, they possess varying transmission patterns among humans. The mode or modes by which a virus transmits from person to person are critical to understanding how the environment in which they transmit impacts person-to-person spread. The Centers for Disease Control and Prevention (CDC) consensus definition for the modes of transmission of influenza virus is broadly applicable to other respiratory (i.e., non-vector-borne) viruses as well (Box 1). In this review, for consistency, we will adhere to the CDC terminology; thus, \"contact transmission\" encompasses both direct and indirect transmission, while \"airborne transmission,\" comprising both droplet spray and aerosol modes, describes the direct inoculation of virus particles from the air into the respiratory tract without an intermediate.\n",
      "\n",
      "\n",
      "Influenza viruses display distinct seasonal patterns in temperate climates with peak infection rates occurring in the winter months and little to no influenza virus activity detected at other times of the year [1] . However, it is not completely understood why we have \"flu seasons\". The same seasonal trends do not necessarily apply to regions in tropic and subtropic climates where influenza virus activity can be detected year round. Social and health factors such as indoor crowding and seasonal fluctuations in host immunity have been offered as explanations for influenza seasonality, but the lack of direct evidence supporting these theories suggests that the environment may be the most relevant contributor and potential driving force of seasonality [1, 2] . Although seasonal influenza viruses display predictable infection patterns, the four most recent influenza virus pandemics began with newly emerged viruses appearing outside the usual influenza season (1918 Spanish Influenza A H1N1, 1957 -1958 Asian Influenza A H2N2, 1968 Hong Kong Influenza A H3N2, 2009 H1N1) [3, 4] . Emergence of the most recent pandemic virus was preceded by reports of sporadic infections of a swine-origin H1N1 virus in young individuals [4, 5] . During the summers of 2010-2014, reports have emerged in the Midwest region of the U.S. of H3N2 variant influenza virus infections in children with a recent history of exposure to swine [6] [7] [8] [9] [10] . These events highlight the importance of closely monitoring emerging strains of influenza viruses throughout the year and the need for our improved understanding of the effects of environmental conditions like temperature and humidity on influenza virus transmission.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THE ECOLOGY AND ADAPTIVE EVOLUTION OF INFLUENZA A INTERSPECIES TRANSMISSION\n",
      "----------------------------------------\n",
      "\n",
      "Viral respiratory tract infections are both ubiquitous and burdensome, accounting for many millions of lost school-and workdays and millions more physician visits each year [1] . Although there are similarities in the clinical syndromes caused by the many viruses capable of infecting and causing disease in the human respiratory tract, they possess varying transmission patterns among humans. The mode or modes by which a virus transmits from person to person are critical to understanding how the environment in which they transmit impacts person-to-person spread. The Centers for Disease Control and Prevention (CDC) consensus definition for the modes of transmission of influenza virus is broadly applicable to other respiratory (i.e., non-vector-borne) viruses as well (Box 1). In this review, for consistency, we will adhere to the CDC terminology; thus, \"contact transmission\" encompasses both direct and indirect transmission, while \"airborne transmission,\" comprising both droplet spray and aerosol modes, describes the direct inoculation of virus particles from the air into the respiratory tract without an intermediate.\n",
      "\n",
      "\n",
      "Influenza A virus (IAV) has caused significant morbidity and mortality globally in humans, with an estimated 14 pandemics that have occurred since the 1500s. 1 Wild aquatic birds are well known to be the natural reservoirs for IAV subtypes harbouring H1-H16 subtypes, 2-4 with the exception of H17 and H18 subtypes that were recently discovered in bats. 5, 6 The phylogenetic relationships of all IAV subtypes are displayed in Fig. 1 . In addition to its natural reservoir species, influenza viruses infect a wide range of hosts including canids, equids, humans and swine. 2 IAVs' ability to generate novel gene constellations through reassortment between subtypes poses a risk for immune escape in these new hosts. 7 Furthermore, IAV undergoes rapid genetic and antigenic evolution, which makes vaccination control difficult in humans and other domestic species.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "IONIZING AIR AFFECTS INFLUENZA VIRUS INFECTIVITY AND PREVENTS AIRBORNE- TRANSMISSION OPEN\n",
      "----------------------------------------\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Viral respiratory tract infections are both ubiquitous and burdensome, accounting for many millions of lost school-and workdays and millions more physician visits each year [1] . Although there are similarities in the clinical syndromes caused by the many viruses capable of infecting and causing disease in the human respiratory tract, they possess varying transmission patterns among humans. The mode or modes by which a virus transmits from person to person are critical to understanding how the environment in which they transmit impacts person-to-person spread. The Centers for Disease Control and Prevention (CDC) consensus definition for the modes of transmission of influenza virus is broadly applicable to other respiratory (i.e., non-vector-borne) viruses as well (Box 1). In this review, for consistency, we will adhere to the CDC terminology; thus, \"contact transmission\" encompasses both direct and indirect transmission, while \"airborne transmission,\" comprising both droplet spray and aerosol modes, describes the direct inoculation of virus particles from the air into the respiratory tract without an intermediate.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "HVAC FILTRATION FOR CONTROLLING INFECTIOUS AIRBORNE DISEASE TRANSMISSION IN INDOOR ENVIRONMENTS: PREDICTING RISK REDUCTIONS AND OPERATIONAL COSTS\n",
      "----------------------------------------\n",
      "\n",
      "The airborne transmission of respiratory pathogens such as measles, tuberculosis, severe acute respiratory syndrome (SARS), influenza, rhinovirus, and others in indoor environments and the associated risk of infection presented to uninfected occupants are governed by several complex physical and biological processes. Communicable respiratory illnesses lead to large excesses in expenses associated with healthcare, absence from work, and lost worker productivity [1] , but the control of airborne infectious disease transmission in indoor environments is not yet entirely understood [2] . Several studies have shown that building design and operational characteristics such as increased outdoor air ventilation rates, lower occupant density, and use of UV germicidal irradiation can reduce the risk of infectious disease transmission inside buildings [3e7] . Similarly, commonly available particle filters in recirculating heating, ventilating, and air-conditioning (HVAC) systems may also be used to reduce the risk of airborne infectious disease transmission, depending on the nature of infectious aerosols and some important building characteristics [2,4,8e12] .\n",
      "\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "ADAPTIVE CONTACT NETWORKS CHANGE EFFECTIVE DISEASE INFECTIOUSNESS AND DYNAMICS\n",
      "----------------------------------------\n",
      "\n",
      "The airborne transmission of respiratory pathogens such as measles, tuberculosis, severe acute respiratory syndrome (SARS), influenza, rhinovirus, and others in indoor environments and the associated risk of infection presented to uninfected occupants are governed by several complex physical and biological processes. Communicable respiratory illnesses lead to large excesses in expenses associated with healthcare, absence from work, and lost worker productivity [1] , but the control of airborne infectious disease transmission in indoor environments is not yet entirely understood [2] . Several studies have shown that building design and operational characteristics such as increased outdoor air ventilation rates, lower occupant density, and use of UV germicidal irradiation can reduce the risk of infectious disease transmission inside buildings [3e7] . Similarly, commonly available particle filters in recirculating heating, ventilating, and air-conditioning (HVAC) systems may also be used to reduce the risk of airborne infectious disease transmission, depending on the nature of infectious aerosols and some important building characteristics [2,4,8e12] .\n",
      "\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SEQUENTIAL ADAPTIVE MUTATIONS ENHANCE EFFICIENT VECTOR SWITCHING BY CHIKUNGUNYA VIRUS AND ITS EPIDEMIC EMERGENCE\n",
      "----------------------------------------\n",
      "\n",
      "The airborne transmission of respiratory pathogens such as measles, tuberculosis, severe acute respiratory syndrome (SARS), influenza, rhinovirus, and others in indoor environments and the associated risk of infection presented to uninfected occupants are governed by several complex physical and biological processes. Communicable respiratory illnesses lead to large excesses in expenses associated with healthcare, absence from work, and lost worker productivity [1] , but the control of airborne infectious disease transmission in indoor environments is not yet entirely understood [2] . Several studies have shown that building design and operational characteristics such as increased outdoor air ventilation rates, lower occupant density, and use of UV germicidal irradiation can reduce the risk of infectious disease transmission inside buildings [3e7] . Similarly, commonly available particle filters in recirculating heating, ventilating, and air-conditioning (HVAC) systems may also be used to reduce the risk of airborne infectious disease transmission, depending on the nature of infectious aerosols and some important building characteristics [2,4,8e12] .\n",
      "\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "ASSOCIATION BETWEEN VIRAL SEASONALITY AND METEOROLOGICAL FACTORS\n",
      "----------------------------------------\n",
      "\n",
      "The airborne transmission of respiratory pathogens such as measles, tuberculosis, severe acute respiratory syndrome (SARS), influenza, rhinovirus, and others in indoor environments and the associated risk of infection presented to uninfected occupants are governed by several complex physical and biological processes. Communicable respiratory illnesses lead to large excesses in expenses associated with healthcare, absence from work, and lost worker productivity [1] , but the control of airborne infectious disease transmission in indoor environments is not yet entirely understood [2] . Several studies have shown that building design and operational characteristics such as increased outdoor air ventilation rates, lower occupant density, and use of UV germicidal irradiation can reduce the risk of infectious disease transmission inside buildings [3e7] . Similarly, commonly available particle filters in recirculating heating, ventilating, and air-conditioning (HVAC) systems may also be used to reduce the risk of airborne infectious disease transmission, depending on the nature of infectious aerosols and some important building characteristics [2,4,8e12] .\n",
      "\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SPATIALLY ADJUSTED TIME- VARYING REPRODUCTIVE NUMBERS: UNDERSTANDING THE GEOGRAPHICAL EXPANSION OF URBAN DENGUE OUTBREAKS\n",
      "----------------------------------------\n",
      "\n",
      "The airborne transmission of respiratory pathogens such as measles, tuberculosis, severe acute respiratory syndrome (SARS), influenza, rhinovirus, and others in indoor environments and the associated risk of infection presented to uninfected occupants are governed by several complex physical and biological processes. Communicable respiratory illnesses lead to large excesses in expenses associated with healthcare, absence from work, and lost worker productivity [1] , but the control of airborne infectious disease transmission in indoor environments is not yet entirely understood [2] . Several studies have shown that building design and operational characteristics such as increased outdoor air ventilation rates, lower occupant density, and use of UV germicidal irradiation can reduce the risk of infectious disease transmission inside buildings [3e7] . Similarly, commonly available particle filters in recirculating heating, ventilating, and air-conditioning (HVAC) systems may also be used to reduce the risk of airborne infectious disease transmission, depending on the nature of infectious aerosols and some important building characteristics [2,4,8e12] .\n",
      "\n",
      "\n",
      "Visualization and efficiency of aerosol sampling as determined by electron microscopy. To develop and validate the ionizing technique for collection and identification of viral pathogens, we used several viruses of clinical importance; calicivirus, rotavirus and influenza virus (H3N2, strain Salomon Island) as well as latex particles. Canine calicivirus (CaCV, strain 48) was used as a surrogate 27 for human norovirus, the aetiological agent behind the \"winter vomiting disease\", causing outbreaks of great clinical and economic importance 28 . Rhesus rotavirus was used as a surrogate marker for human rotavirus 29 .\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 1\n",
    "tags = \"transmission incubation environment seasonality\"\n",
    "show_relevant_articles(1, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 121,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "RESPIRATORY DISEASE IN PREGNANCY\n",
      "----------------------------------------\n",
      "\n",
      "Severe chest disease leading to respiratory failure is uncommon in women of childbearing age but respiratory symptoms are extremely common in pregnancy. This is in part an effect of the physiological adaptation of the respiratory and vascular systems to pregnancy and in part because of limited functional capacity and mobility from diaphragmatic elevation by the gravid uterus in late gestation. Oxygen consumption is increased by 20% from early pregnancy, minute ventilation by 40-50% secondary to tidal volume increase, and maternal hyperventilation results in a mild fully compensated respiratory alkalosis (increased arterial pO 2 and decreased arterial pCO 2 , compensatory fall in serum bicarbonate to 18-22 mmol/l; arterial pH 7.44).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "EXERCISE AND INFECTION RISK\n",
      "----------------------------------------\n",
      "\n",
      "Severe chest disease leading to respiratory failure is uncommon in women of childbearing age but respiratory symptoms are extremely common in pregnancy. This is in part an effect of the physiological adaptation of the respiratory and vascular systems to pregnancy and in part because of limited functional capacity and mobility from diaphragmatic elevation by the gravid uterus in late gestation. Oxygen consumption is increased by 20% from early pregnancy, minute ventilation by 40-50% secondary to tidal volume increase, and maternal hyperventilation results in a mild fully compensated respiratory alkalosis (increased arterial pO 2 and decreased arterial pCO 2 , compensatory fall in serum bicarbonate to 18-22 mmol/l; arterial pH 7.44).\n",
      "\n",
      "\n",
      "Upper respiratory tract infections (URTI) such as coughs and colds, throat infections and middle ear infections are a leading cause of visits to general practitioners throughout the world (Graham 1990) . Given that the average adult suffers from two to five colds each year (Heath et al 1992) it is not surprising that the socioeconomic consequences of these illnesses are considerable in terms of days lost from work and costs of medical consultation, care and over-the-counter remedies. As such, these illnesses present a real concern to the wellbeing of both athletes and the general population and therefore an understanding of the relationship between physical activity and infection risk is of great importance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "PREGNANCY AND PERINATAL OUTCOMES OF WOMEN WITH SEVERE ACUTE RESPIRATORY SYNDROME\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Severe chest disease leading to respiratory failure is uncommon in women of childbearing age but respiratory symptoms are extremely common in pregnancy. This is in part an effect of the physiological adaptation of the respiratory and vascular systems to pregnancy and in part because of limited functional capacity and mobility from diaphragmatic elevation by the gravid uterus in late gestation. Oxygen consumption is increased by 20% from early pregnancy, minute ventilation by 40-50% secondary to tidal volume increase, and maternal hyperventilation results in a mild fully compensated respiratory alkalosis (increased arterial pO 2 and decreased arterial pCO 2 , compensatory fall in serum bicarbonate to 18-22 mmol/l; arterial pH 7.44).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SEVERE MORBIDITY AND MORTALITY ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS VERSUS INFLUENZA INFECTION IN HOSPITALIZED OLDER ADULTS\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Severe chest disease leading to respiratory failure is uncommon in women of childbearing age but respiratory symptoms are extremely common in pregnancy. This is in part an effect of the physiological adaptation of the respiratory and vascular systems to pregnancy and in part because of limited functional capacity and mobility from diaphragmatic elevation by the gravid uterus in late gestation. Oxygen consumption is increased by 20% from early pregnancy, minute ventilation by 40-50% secondary to tidal volume increase, and maternal hyperventilation results in a mild fully compensated respiratory alkalosis (increased arterial pO 2 and decreased arterial pCO 2 , compensatory fall in serum bicarbonate to 18-22 mmol/l; arterial pH 7.44).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CLINICAL PRESENTATION AND BIRTH OUTCOMES ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS INFECTION IN PREGNANCY\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Respiratory syncytial virus (RSV) is the most important cause of acute lower respiratory infection (ALRI) in children worldwide [1] . RSV antibody protects young infants from severe ALRI. No RSV vaccines are currently licensed, though a RSV vaccine for use in pregnant women recently completed a phase II clinical trial in the United States [2, 3] . A RSV vaccine administered during pregnancy has the potential to protect the infant through transplacental antibody transfer and to decrease maternal RSV illness incidence and severity.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "RISK FACTORS FOR SEVERE BRONCHIOLITIS CAUSED BY RESPIRATORY VIRUS INFECTIONS AMONG MEXICAN CHILDREN IN AN EMERGENCY DEPARTMENT\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Respiratory syncytial virus (RSV) is the most important cause of acute lower respiratory infection (ALRI) in children worldwide [1] . RSV antibody protects young infants from severe ALRI. No RSV vaccines are currently licensed, though a RSV vaccine for use in pregnant women recently completed a phase II clinical trial in the United States [2, 3] . A RSV vaccine administered during pregnancy has the potential to protect the infant through transplacental antibody transfer and to decrease maternal RSV illness incidence and severity.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CLINICAL CHARACTERISTICS AND OUTCOMES OF RESPIRATORY SYNCYTIAL VIRUS INFECTION IN PREGNANT WOMEN\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Infection with respiratory pathogens during pregnancy can result in mild to severe acute respiratory illness (ARI). Due to the physiologic changes that occur during pregnancy, pregnant women may experience severe outcomes when infected with a respiratory pathogen [1] . Infection with influenza during pregnancy has been associated with an increased risk of maternal mortality, preterm birth, and infants that are small for gestational age [2, 3] . To prevent these adverse maternal and fetal outcomes, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommends immunization with influenza vaccine during pregnancy [4] . The ACIP also recommends maternal immunization with the Tetanus-Diphtheria-acellular Pertussis (Tdap) vaccine [5] given that, although adult infection with pertussis is often mild, maternal antibodies transferred to the infant can prevent pertussis-related morbidity and mortality in this vulnerable age group [6] . Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) among infants and young children, contributing significantly to morbidity and mortality in these populations [7] [8] [9] . There is currently a robust pipeline of RSV vaccine candidates in various preclinical and clinical phases of development. One strategy targets protection of infants less than three months of age through maternal vaccination. Maternal RSV antibodies are efficiently transferred transplacentally to the fetus during gestation, and have been associated with decreased risk of RSV infection in young infants [10] [11] [12] . For this reason, maternal immunization appears to be a promising strategy to prevent severe RSV disease in infants. However, the direct benefit to pregnant women from maternal immunization against RSV is currently unknown.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "RISK OF MORTALITY ASSOCIATED WITH RESPIRATORY SYNCYTIAL VIRUS AND INFLUENZA INFECTION IN ADULTS\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Infection with respiratory pathogens during pregnancy can result in mild to severe acute respiratory illness (ARI). Due to the physiologic changes that occur during pregnancy, pregnant women may experience severe outcomes when infected with a respiratory pathogen [1] . Infection with influenza during pregnancy has been associated with an increased risk of maternal mortality, preterm birth, and infants that are small for gestational age [2, 3] . To prevent these adverse maternal and fetal outcomes, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommends immunization with influenza vaccine during pregnancy [4] . The ACIP also recommends maternal immunization with the Tetanus-Diphtheria-acellular Pertussis (Tdap) vaccine [5] given that, although adult infection with pertussis is often mild, maternal antibodies transferred to the infant can prevent pertussis-related morbidity and mortality in this vulnerable age group [6] . Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) among infants and young children, contributing significantly to morbidity and mortality in these populations [7] [8] [9] . There is currently a robust pipeline of RSV vaccine candidates in various preclinical and clinical phases of development. One strategy targets protection of infants less than three months of age through maternal vaccination. Maternal RSV antibodies are efficiently transferred transplacentally to the fetus during gestation, and have been associated with decreased risk of RSV infection in young infants [10] [11] [12] . For this reason, maternal immunization appears to be a promising strategy to prevent severe RSV disease in infants. However, the direct benefit to pregnant women from maternal immunization against RSV is currently unknown.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "VIRUSES CAUSING LOWER RESPIRATORY SYMPTOMS IN YOUNG CHILDREN: FINDINGS FROM THE ORCHID BIRTH COHORT RESPIRATORY INFECTION\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Infection with respiratory pathogens during pregnancy can result in mild to severe acute respiratory illness (ARI). Due to the physiologic changes that occur during pregnancy, pregnant women may experience severe outcomes when infected with a respiratory pathogen [1] . Infection with influenza during pregnancy has been associated with an increased risk of maternal mortality, preterm birth, and infants that are small for gestational age [2, 3] . To prevent these adverse maternal and fetal outcomes, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommends immunization with influenza vaccine during pregnancy [4] . The ACIP also recommends maternal immunization with the Tetanus-Diphtheria-acellular Pertussis (Tdap) vaccine [5] given that, although adult infection with pertussis is often mild, maternal antibodies transferred to the infant can prevent pertussis-related morbidity and mortality in this vulnerable age group [6] . Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) among infants and young children, contributing significantly to morbidity and mortality in these populations [7] [8] [9] . There is currently a robust pipeline of RSV vaccine candidates in various preclinical and clinical phases of development. One strategy targets protection of infants less than three months of age through maternal vaccination. Maternal RSV antibodies are efficiently transferred transplacentally to the fetus during gestation, and have been associated with decreased risk of RSV infection in young infants [10] [11] [12] . For this reason, maternal immunization appears to be a promising strategy to prevent severe RSV disease in infants. However, the direct benefit to pregnant women from maternal immunization against RSV is currently unknown.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "STATINS MAY DECREASE THE FATALITY RATE OF MIDDLE EAST RESPIRATORY SYNDROME INFECTION\n",
      "----------------------------------------\n",
      "\n",
      "Since November 2002, severe acute respiratory syndrome (SARS) has affected 8437 persons and has caused more than 800 deaths worldwide. 1 SARS is a new disease caused by a novel coronavirus 2,3 that causes atypical pneumonia, which may progress to respiratory failure. 4 It appeared that the SARS outbreak was currently under controlled, though the problem may re-emerge during the winter. There is no published information on the outcomes of pregnant women infected with SARS. Given the significant maternal and perinatal morbidity and mortality of most viral pneumonia in pregnancy, SARS may impose greater risk in pregnant compared to nonpregnant individuals. We reported the pregnancy and perinatal outcomes of all pregnant women affected during the outbreak in Hong Kong.\n",
      "\n",
      "\n",
      "Infection with respiratory pathogens during pregnancy can result in mild to severe acute respiratory illness (ARI). Due to the physiologic changes that occur during pregnancy, pregnant women may experience severe outcomes when infected with a respiratory pathogen [1] . Infection with influenza during pregnancy has been associated with an increased risk of maternal mortality, preterm birth, and infants that are small for gestational age [2, 3] . To prevent these adverse maternal and fetal outcomes, the Advisory Committee on Immunization Practices (ACIP) of the Centers for Disease Control and Prevention recommends immunization with influenza vaccine during pregnancy [4] . The ACIP also recommends maternal immunization with the Tetanus-Diphtheria-acellular Pertussis (Tdap) vaccine [5] given that, although adult infection with pertussis is often mild, maternal antibodies transferred to the infant can prevent pertussis-related morbidity and mortality in this vulnerable age group [6] . Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract illness (LRTI) among infants and young children, contributing significantly to morbidity and mortality in these populations [7] [8] [9] . There is currently a robust pipeline of RSV vaccine candidates in various preclinical and clinical phases of development. One strategy targets protection of infants less than three months of age through maternal vaccination. Maternal RSV antibodies are efficiently transferred transplacentally to the fetus during gestation, and have been associated with decreased risk of RSV infection in young infants [10] [11] [12] . For this reason, maternal immunization appears to be a promising strategy to prevent severe RSV disease in infants. However, the direct benefit to pregnant women from maternal immunization against RSV is currently unknown.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 3\n",
    "tags = 'risk smoking infections pregnancy fatality'\n",
    "show_relevant_articles(2, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "THE EVOLUTION AND GENETICS OF VIRUS HOST SHIFTS\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "VIRUSES THE BROAD HOST RANGE AND GENETIC DIVERSITY OF MAMMALIAN AND AVIAN ASTROVIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "Astroviruses (AstVs) were first described in 1975 as small viruses that are 28-30 nm in diameter with icosahedral morphology. Astroviruses are named due to the distinct five-pointed or six-pointed star-like appearance of some virions when visualized under an electron microscope (EM); astrovirus is derived from the Greek word astron meaning star [1] [2] [3] . Astroviruses were first described from human infants with diarrhea and were subsequently identified in the young of numerous mammalian and avian species [4, 5] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THE DIVERSITY, EVOLUTION AND ORIGINS OF VERTEBRATE RNA VIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "Astroviruses (AstVs) were first described in 1975 as small viruses that are 28-30 nm in diameter with icosahedral morphology. Astroviruses are named due to the distinct five-pointed or six-pointed star-like appearance of some virions when visualized under an electron microscope (EM); astrovirus is derived from the Greek word astron meaning star [1] [2] [3] . Astroviruses were first described from human infants with diarrhea and were subsequently identified in the young of numerous mammalian and avian species [4, 5] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "EVOLUTION AND GENETIC DIVERSITY OF PORCINE CIRCOVIRUS 3 IN CHINA\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The Circovirus genus claimed veterinarians' attention shortly after its discovery, most members infect avian species but swine also serve as natural hosts [1, 2] . PCV1 and PCV2 are infectious agents in swine [3] ; PCV1 was first detected as a contaminant of PK-15 cell cultures and has not been associated with clinical disease, PCV2 is a ubiquitous, economically important pathogen to the swine industry [4] . PCV2 infection leads to a diverse range of clinical diseases collectively termed PCV2-associated disease (PCVAD), which includes post-weaning multi-systemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), interstitial pneumonia, enteric disease, and reproductive failure [5] . Porcine Circovirus 3 (PCV3) is the third member of the Circovirus genus to infect swine [6] , it has a circular ssDNA genome of approximatively 2000 bases containing three identified ORFs [6] , although only ORF1 and ORF2 have been characterized. ORF1, located on the positive strand, apparently codes for a single replication-associated protein (Rep) of 296-297 aa [6] . ORF2 is on the negative strand and encodes the capsid protein (Cap). Despite the common genomic organization, PCV3 is distantly related to other known circoviruses, although a relatively close relationship with bat circoviruses has been suggested based on phylogenetic analysis [7] . There is also some unresolved opinion on the genotyping of PCV3. For example, Li et al. divide PCV3 into 3a and 3b, while Ouyang et al. suggest that PCV3 can be divided into PCV3a, 3b and 3c [7, 8] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "DOES GENETIC DIVERSITY LIMIT DISEASE SPREAD IN NATURAL HOST POPULATIONS?\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The Circovirus genus claimed veterinarians' attention shortly after its discovery, most members infect avian species but swine also serve as natural hosts [1, 2] . PCV1 and PCV2 are infectious agents in swine [3] ; PCV1 was first detected as a contaminant of PK-15 cell cultures and has not been associated with clinical disease, PCV2 is a ubiquitous, economically important pathogen to the swine industry [4] . PCV2 infection leads to a diverse range of clinical diseases collectively termed PCV2-associated disease (PCVAD), which includes post-weaning multi-systemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), interstitial pneumonia, enteric disease, and reproductive failure [5] . Porcine Circovirus 3 (PCV3) is the third member of the Circovirus genus to infect swine [6] , it has a circular ssDNA genome of approximatively 2000 bases containing three identified ORFs [6] , although only ORF1 and ORF2 have been characterized. ORF1, located on the positive strand, apparently codes for a single replication-associated protein (Rep) of 296-297 aa [6] . ORF2 is on the negative strand and encodes the capsid protein (Cap). Despite the common genomic organization, PCV3 is distantly related to other known circoviruses, although a relatively close relationship with bat circoviruses has been suggested based on phylogenetic analysis [7] . There is also some unresolved opinion on the genotyping of PCV3. For example, Li et al. divide PCV3 into 3a and 3b, while Ouyang et al. suggest that PCV3 can be divided into PCV3a, 3b and 3c [7, 8] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MOLECULAR EVOLUTION AND EMERGENCE OF AVIAN GAMMACORONAVIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The majority of emerging infectious diseases are caused by RNA viruses. High rates of mutation, short generation times and large population sizes drive their rapid evolution. A wide variety of animals, including humans, are affected and examples include severe acute respiratory syndrome coronavirus (SARS-CoV), influenza virus, human immunodeficiency virus, poliovirus, hepatitis A, B, and C virus, yellow fever virus, dengue virus, West Nile virus, and many others (Lai and Holmes, 2001) . Understanding viral evolution is important because it can lead to outbreaks of known diseases (e.g. the 2009 human pandemic H1N1 influenza virus), host shifts and the emergence of new diseases (e.g. hantavirus), as well as escape from immune response and antiviral drugs (e.g. human immunodeficiency virus).\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "ORIGIN, GENETIC DIVERSITY, AND EVOLUTIONARY DYNAMICS OF NOVEL PORCINE CIRCOVIRUS 3\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The majority of emerging infectious diseases are caused by RNA viruses. High rates of mutation, short generation times and large population sizes drive their rapid evolution. A wide variety of animals, including humans, are affected and examples include severe acute respiratory syndrome coronavirus (SARS-CoV), influenza virus, human immunodeficiency virus, poliovirus, hepatitis A, B, and C virus, yellow fever virus, dengue virus, West Nile virus, and many others (Lai and Holmes, 2001) . Understanding viral evolution is important because it can lead to outbreaks of known diseases (e.g. the 2009 human pandemic H1N1 influenza virus), host shifts and the emergence of new diseases (e.g. hantavirus), as well as escape from immune response and antiviral drugs (e.g. human immunodeficiency virus).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "VIRUSES RELIABLE AND STANDARDIZED ANIMAL MODELS TO STUDY THE PATHOGENESIS OF BLUETONGUE AND SCHMALLENBERG VIRUSES IN RUMINANT NATURAL HOST SPECIES WITH SPECIAL EMPHASIS ON PLACENTAL CROSSING\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The majority of emerging infectious diseases are caused by RNA viruses. High rates of mutation, short generation times and large population sizes drive their rapid evolution. A wide variety of animals, including humans, are affected and examples include severe acute respiratory syndrome coronavirus (SARS-CoV), influenza virus, human immunodeficiency virus, poliovirus, hepatitis A, B, and C virus, yellow fever virus, dengue virus, West Nile virus, and many others (Lai and Holmes, 2001) . Understanding viral evolution is important because it can lead to outbreaks of known diseases (e.g. the 2009 human pandemic H1N1 influenza virus), host shifts and the emergence of new diseases (e.g. hantavirus), as well as escape from immune response and antiviral drugs (e.g. human immunodeficiency virus).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "GENOMIC ORGANIZATION AND ADAPTIVE EVOLUTION OF IGHC GENES IN MARINE MAMMALS\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n",
      "The majority of emerging infectious diseases are caused by RNA viruses. High rates of mutation, short generation times and large population sizes drive their rapid evolution. A wide variety of animals, including humans, are affected and examples include severe acute respiratory syndrome coronavirus (SARS-CoV), influenza virus, human immunodeficiency virus, poliovirus, hepatitis A, B, and C virus, yellow fever virus, dengue virus, West Nile virus, and many others (Lai and Holmes, 2001) . Understanding viral evolution is important because it can lead to outbreaks of known diseases (e.g. the 2009 human pandemic H1N1 influenza virus), host shifts and the emergence of new diseases (e.g. hantavirus), as well as escape from immune response and antiviral drugs (e.g. human immunodeficiency virus).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "ANIMAL VIRUS ECOLOGY AND EVOLUTION ARE SHAPED BY THE VIRUS HOST-BODY\n",
      "----------------------------------------\n",
      "\n",
      "ecologies, poultry plus pig production and ruminant plus equine husbandry, as well as to 23 create a distinction among the RNA, DNA and retroviruses, also ranked in an outer-to inner-24 body fashion. Spearman correlation reveals the matches among these various virus traits, as 25 pertaining to the two host-ecologies, four infection-shedding-transmission related variables, 26 and the three virus genomes. The collective results reveal the outer-to inner-body shifts in 27 the interplay of host environment, virus-host interactions, and nature of the virus. Two 28 opposing virus evolution pathways emerge, respectively for generalist type, outer-body and 29 for specialist type, inner-body viruses. The ecological virus classification here presented is 30 broadly consistent with the current virus classification system and offers the advantage of 31 bringing substance and cohesion to the interrelationships among viruses and virus families.\n",
      "\n",
      "\n",
      "Emerging infectious diseases affecting humans, wildlife, and agriculture are often the result of a pathogen jumping from its original host into a novel host species. This can take the form of spillover events that result in dead end infections or short stuttering transmission chains, or a host shift with successful infection and sustained transmission in the new host (Box 1). Host shifts have resulted in multiple human pandemics, such as HIV from chimps [1] and the H1N1 ''Spanish flu'' from birds [2] , which have both killed tens of millions of people. Other important human pathogens have originated from other host species, including Plasmodium falciparum [3] , SARS coronavirus [4] , Hendra and Nipah viruses [5] , and the measles virus [6] . Past host shifts can be detected when the phylogenies of hosts and their pathogens are different (phylogenetic incongruence-Box 1). This is very common, with a survey of the published literature finding 93% of studies comparing host and pathogen phylogenies showed evidence of host shifts [7] , and there are relatively few cases where the pathogen phylogeny mirrors that of its host completely [8] .\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 3\n",
    "tags = 'genetics origin evolution animal range host'\n",
    "show_relevant_articles(3, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "THERAPEUTICS AND VACCINES\n",
      "----------------------------------------\n",
      "\n",
      "A novel human coronavirus, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), was identified as a pathogen causing a severe acute respiratory syndrome (SARS)-like disease in the Middle East and Europe in 2012 [1] . As of October 14, 2013, the World Health Organization (WHO) had been informed of 138 confirmed cases of MERS-CoV infection, including 60 deaths (a case fatality rate of 45%) (http://www.who.int/csr/don/ 2013_10_14/en/). Recent reports of family clusters and health care-associated transmission of MERS-CoV through close contact have proven its capacity for human-to-human transmission [2] [3] [4] [5] . Although its transmissibility is significantly lower than that of SARS coronavirus (SARS-CoV) [6] [7] [8] [9] , it may gain increased human-to-human transmissibility during its further evolution and potentially cause a pandemic in the future [10] . Accordingly, development of effective therapeutics and vaccines is critical for early intervention and prevention.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MONOCLONAL ANTIBODY-BASED THERAPIES FOR MICROBIAL DISEASES\n",
      "----------------------------------------\n",
      "\n",
      "A novel human coronavirus, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), was identified as a pathogen causing a severe acute respiratory syndrome (SARS)-like disease in the Middle East and Europe in 2012 [1] . As of October 14, 2013, the World Health Organization (WHO) had been informed of 138 confirmed cases of MERS-CoV infection, including 60 deaths (a case fatality rate of 45%) (http://www.who.int/csr/don/ 2013_10_14/en/). Recent reports of family clusters and health care-associated transmission of MERS-CoV through close contact have proven its capacity for human-to-human transmission [2] [3] [4] [5] . Although its transmissibility is significantly lower than that of SARS coronavirus (SARS-CoV) [6] [7] [8] [9] , it may gain increased human-to-human transmissibility during its further evolution and potentially cause a pandemic in the future [10] . Accordingly, development of effective therapeutics and vaccines is critical for early intervention and prevention.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "VACCINES AND THERAPEUTICS AGAINST HANTAVIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "A novel human coronavirus, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), was identified as a pathogen causing a severe acute respiratory syndrome (SARS)-like disease in the Middle East and Europe in 2012 [1] . As of October 14, 2013, the World Health Organization (WHO) had been informed of 138 confirmed cases of MERS-CoV infection, including 60 deaths (a case fatality rate of 45%) (http://www.who.int/csr/don/ 2013_10_14/en/). Recent reports of family clusters and health care-associated transmission of MERS-CoV through close contact have proven its capacity for human-to-human transmission [2] [3] [4] [5] . Although its transmissibility is significantly lower than that of SARS coronavirus (SARS-CoV) [6] [7] [8] [9] , it may gain increased human-to-human transmissibility during its further evolution and potentially cause a pandemic in the future [10] . Accordingly, development of effective therapeutics and vaccines is critical for early intervention and prevention.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MOLECULES PHARMACOLOGICAL AND BIOLOGICAL ANTIVIRAL THERAPEUTICS FOR CARDIAC COXSACKIEVIRUS INFECTIONS\n",
      "----------------------------------------\n",
      "\n",
      "Myocarditis is defined as a subclinical inflammation of the heart muscle and may be induced by infectious, toxic or immunologic agents. Among the different infectious pathogens viruses are the most common causes of myocarditis [1] and serological studies, nucleic-acid hybridization and PCR-based studies of endomyocardial biopsy and autopsy specimens have shown that enteroviruses represent one of the most common groups of viruses detected in the myocardium [2] . Although myocarditis is a frequent disease, it often goes unrecognized. Based on more than 12,500 randomly selected routine autopsies performed over a 10 year period about 1% of the population were found to have lymphocytic myocarditis [3] . In most cases myocarditis is detected in the group of young adults between the ages of 20 and 39 [4] .\n",
      "\n",
      "\n",
      "A novel human coronavirus, Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV), was identified as a pathogen causing a severe acute respiratory syndrome (SARS)-like disease in the Middle East and Europe in 2012 [1] . As of October 14, 2013, the World Health Organization (WHO) had been informed of 138 confirmed cases of MERS-CoV infection, including 60 deaths (a case fatality rate of 45%) (http://www.who.int/csr/don/ 2013_10_14/en/). Recent reports of family clusters and health care-associated transmission of MERS-CoV through close contact have proven its capacity for human-to-human transmission [2] [3] [4] [5] . Although its transmissibility is significantly lower than that of SARS coronavirus (SARS-CoV) [6] [7] [8] [9] , it may gain increased human-to-human transmissibility during its further evolution and potentially cause a pandemic in the future [10] . Accordingly, development of effective therapeutics and vaccines is critical for early intervention and prevention.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "NEW CLASS OF MONOCLONAL ANTIBODIES AGAINST SEVERE INFLUENZA: PROPHYLACTIC AND THERAPEUTIC EFFICACY IN FERRETS\n",
      "----------------------------------------\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n",
      "Myocarditis is defined as a subclinical inflammation of the heart muscle and may be induced by infectious, toxic or immunologic agents. Among the different infectious pathogens viruses are the most common causes of myocarditis [1] and serological studies, nucleic-acid hybridization and PCR-based studies of endomyocardial biopsy and autopsy specimens have shown that enteroviruses represent one of the most common groups of viruses detected in the myocardium [2] . Although myocarditis is a frequent disease, it often goes unrecognized. Based on more than 12,500 randomly selected routine autopsies performed over a 10 year period about 1% of the population were found to have lymphocytic myocarditis [3] . In most cases myocarditis is detected in the group of young adults between the ages of 20 and 39 [4] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THERAPY WITH CTLA4-IG AND AN ANTIVIRAL MONOCLONAL ANTIBODY CONTROLS CHIKUNGUNYA VIRUS ARTHRITIS\n",
      "----------------------------------------\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n",
      "Myocarditis is defined as a subclinical inflammation of the heart muscle and may be induced by infectious, toxic or immunologic agents. Among the different infectious pathogens viruses are the most common causes of myocarditis [1] and serological studies, nucleic-acid hybridization and PCR-based studies of endomyocardial biopsy and autopsy specimens have shown that enteroviruses represent one of the most common groups of viruses detected in the myocardium [2] . Although myocarditis is a frequent disease, it often goes unrecognized. Based on more than 12,500 randomly selected routine autopsies performed over a 10 year period about 1% of the population were found to have lymphocytic myocarditis [3] . In most cases myocarditis is detected in the group of young adults between the ages of 20 and 39 [4] .\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "CLINICAL DEVELOPMENT OF MONOCLONAL ANTIBODY- BASED DRUGS IN HIV AND HCV DISEASES\n",
      "----------------------------------------\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n",
      "The innate immune response is the first-line defense in determining the outcome of an infection. Infectious agents contain conserved motifs on their surface that react with conserved pattern recognition Toll-like receptors of the host. This interaction initiates a powerful innate immune response. Moreover, the infectious agent's surface proteins and carbohydrates come into contact with B-cell receptors, membrane-bound immunoglobulin of isotype M (IgM) or D (IgD), and often induce potent antibody responses, which take some weeks to fully develop [1] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "HUMAN MONOCLONAL ANTIBODIES AS CANDIDATE THERAPEUTICS AGAINST EMERGING VIRUSES\n",
      "----------------------------------------\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n",
      "The innate immune response is the first-line defense in determining the outcome of an infection. Infectious agents contain conserved motifs on their surface that react with conserved pattern recognition Toll-like receptors of the host. This interaction initiates a powerful innate immune response. Moreover, the infectious agent's surface proteins and carbohydrates come into contact with B-cell receptors, membrane-bound immunoglobulin of isotype M (IgM) or D (IgD), and often induce potent antibody responses, which take some weeks to fully develop [1] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CLINICAL MEDICINE REVIEW ADVANCEMENTS IN NUCLEIC ACID BASED THERAPEUTICS AGAINST RESPIRATORY VIRAL INFECTIONS\n",
      "----------------------------------------\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n",
      "The innate immune response is the first-line defense in determining the outcome of an infection. Infectious agents contain conserved motifs on their surface that react with conserved pattern recognition Toll-like receptors of the host. This interaction initiates a powerful innate immune response. Moreover, the infectious agent's surface proteins and carbohydrates come into contact with B-cell receptors, membrane-bound immunoglobulin of isotype M (IgM) or D (IgD), and often induce potent antibody responses, which take some weeks to fully develop [1] .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THERAPEUTIC APPLICATIONS OF MONOCLONAL ANTIBODIES\n",
      "----------------------------------------\n",
      "\n",
      "I n 1975, Kohler and Milstein revolutionized the field of immunology by developing monoclonal antibodies (MAbs). Since that time, many MAbs have been developed for use in diagnostic procedures and in immunotherapy. Ever since it was observed that the therapeutic use of heterologous MAbs elicited immunogenic responses in humans, significant research efforts have been devoted toward creating chimeric and humanized antibodies for use in human patients. Major achievements have been in the production of MAbs in transgenic plants and animals. The use of phage display libraries has created customized antibodies with defined affinity and specificity. This review describes how rodent, chimeric, and humanized antibodies have each been used, with varying degrees of success to treat cancer, septicemia, autoimmune disorders, and infectious diseases. We also describe here recent applications of antibody engineering, such as the use of bispecific antibodies and antibody fragments in immunotherapy.\n",
      "\n",
      "\n",
      "A novel class of human monoclonal antibodies against influenza has been recently discovered [1] . These antibodies bind to the membrane-proximal stem of haemagglutinin, the major viral surface protein, and neutralize the influenza virus by blocking its fusion with the host cell [2] . A panel of antibodies with a similar mode of action was reported subsequently by Sui et al. [3] . Due to the high conservation of their recognition site, this class of antibodies has shown the ability to neutralize a broad spectrum of influenza subtypes, including H1, H2, H5, H6 and H9 [1] , and can be expected to also neutralize viruses from subtypes H4, H8, H11-H14 and H16, as well as their future antigenic drift variants [2] . One of these antibodies, CR6261, was investigated in mice and shown to be protective when given before and after lethal challenges with H1N1 and H5N1 virus, suggesting that it has potential as the first-ever broad-spectrum monoclonal antibody for prophylaxis and treatment of influenza virus infections [1] .\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 4\n",
    "tags = 'vaccines therapeutics drugs antibody effectiveness'\n",
    "show_relevant_articles(4, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 124,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "RESISTANCE TO SYNTHETIC BLOOD PENETRATION OF NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH-APPROVED N95 FILTERING FACEPIECE RESPIRATORS AND SURGICAL N95 RESPIRATORS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "RESISTANCE TO SYNTHETIC BLOOD PENETRATION OF NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH-APPROVED N95 FILTERING FACEPIECE RESPIRATORS AND SURGICAL N95 RESPIRATORS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THE EFFICACY OF MEDICAL MASKS AND RESPIRATORS AGAINST RESPIRATORY INFECTION IN HEALTHCARE WORKERS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "COST-EFFECTIVENESS ANALYSIS OF N95 RESPIRATORS AND MEDICAL MASKS TO PROTECT HEALTHCARE WORKERS IN CHINA FROM RESPIRATORY INFECTIONS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CLINICAL INFECTIOUS DISEASES HEALTHCARE WORKERS' STRATEGIES FOR DOFFING PERSONAL PROTECTIVE EQUIPMENT\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SPEECH INTELLIGIBILITY ASSESSMENT OF PROTECTIVE FACEMASKS AND AIR-PURIFYING RESPIRATORS HHS PUBLIC ACCESS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "REUSABLE ELASTOMERIC AIR-PURIFYING RESPIRATORS: PHYSIOLOGIC IMPACT ON HEALTH CARE WORKERS\n",
      "----------------------------------------\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "PROTECTING HEALTHCARE STAFF FROM SEVERE ACUTE RESPIRATORY SYNDROME: FILTRATION CAPACITY OF MULTIPLE SURGICAL MASKS\n",
      "----------------------------------------\n",
      "\n",
      "Severe acute respiratory syndrome (SARS) is a highly contagious, potentially life-threatening condition that frequently affects healthcare workers caring for infected patients. 1 The exact mode of transmission is unknown but may involve airborne as well as respiratory droplet and fomite spread. In view of the possibility of airborne transmission, current guidelines issued by the Centers for Disease Control and Prevention (CDC) and the World Health Organisation (WHO) state that healthcare workers should wear N95 masks or higher-level protection during all contact with suspected SARS patients. These masks are expensive and not necessarily easily available in poorer countries. In some areas, multiple layers of surgical masks have been tried to prevent SARS transmission.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "REVIEW OF ECONOMIC EVALUATIONS OF MASK AND RESPIRATOR USE FOR PROTECTION AGAINST RESPIRATORY INFECTION TRANSMISSION\n",
      "----------------------------------------\n",
      "\n",
      "Severe acute respiratory syndrome (SARS) is a highly contagious, potentially life-threatening condition that frequently affects healthcare workers caring for infected patients. 1 The exact mode of transmission is unknown but may involve airborne as well as respiratory droplet and fomite spread. In view of the possibility of airborne transmission, current guidelines issued by the Centers for Disease Control and Prevention (CDC) and the World Health Organisation (WHO) state that healthcare workers should wear N95 masks or higher-level protection during all contact with suspected SARS patients. These masks are expensive and not necessarily easily available in poorer countries. In some areas, multiple layers of surgical masks have been tried to prevent SARS transmission.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "THE RESPIRATORY PROTECTION EFFECTIVENESS CLINICAL TRIAL (RESPECT): A CLUSTER- RANDOMIZED COMPARISON OF RESPIRATOR AND MEDICAL MASK EFFECTIVENESS AGAINST RESPIRATORY INFECTIONS IN HEALTHCARE PERSONNEL\n",
      "----------------------------------------\n",
      "\n",
      "Severe acute respiratory syndrome (SARS) is a highly contagious, potentially life-threatening condition that frequently affects healthcare workers caring for infected patients. 1 The exact mode of transmission is unknown but may involve airborne as well as respiratory droplet and fomite spread. In view of the possibility of airborne transmission, current guidelines issued by the Centers for Disease Control and Prevention (CDC) and the World Health Organisation (WHO) state that healthcare workers should wear N95 masks or higher-level protection during all contact with suspected SARS patients. These masks are expensive and not necessarily easily available in poorer countries. In some areas, multiple layers of surgical masks have been tried to prevent SARS transmission.\n",
      "\n",
      "\n",
      "Surgical mask (SM) or facemask refers to the Food and Drug Administration (FDA)-cleared surgical, laser, isolation, dental, and medical procedure masks with or without a face shield. A SM covers the user's nose and mouth and provides a physical barrier to splashes/sprays of large droplets of body fluids. 1 SMs are used by health care personnel during surgical and nonsurgical procedures to protect both the patient and the health care worker from splashes/ sprays of blood or other body fluids. 2 FDA clears SMs based on manufacturer-submitted test data and proposed claims. 3 Manufacturers submit the test results for particle filtration efficiency, bacterial filtration efficiency, fluid resistance, differential pressure, and flammability for FDA clearance. 3 The use of respirators certified by the National Institute for Occupational Safety and Health (NIOSH), at least as protective as a N95 filtering facepiece respirator (N95 FFR), is recommended during care of patients with diseases such as tuberculosis and measles and during aerosol-generating procedures on patients with certain infectious diseases (eg, seasonal influenza, novel influenza A, and Ebola virus disease). [4] [5] [6] [7] NIOSH tests and certifies the performance of FFRs according to requirements outlined in the US Title 42 Code of Federal Regulations (CFR) Part 84. 8 For N95 FFRs, the primary tests are filtration efficiency and airflow resistance.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 5\n",
    "tags = 'medical manifestations respirators technologies protection'\n",
    "show_relevant_articles(5, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 126,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "MASS GATHERINGS MEDICINE: PUBLIC HEALTH ISSUES ARISING FROM MASS GATHERING RELIGIOUS AND SPORTING EVENTS\n",
      "----------------------------------------\n",
      "\n",
      "A mass gathering is defined by WHO as a planned or spontaneous event that gathers substantial numbers of attendees who might strain the health planning and response capacities of the host community, city, or country. 1 Mass gatherings can present important public health challenges related to the health of attendees and of the host country population and health services. 2 The concept of mass gathering medicine as a specialty emanated from discourse on the 2009 Hajj, which was held during the 2009 HIN1 influenza pandemic (panel 1). 3 The first International Conference on Mass Gatherings Medicine was held in Jeddah, Saudi Arabia, in October, 2010, where The Lancet Infectious Diseases Series on mass gatherings was launched (panel 1). 4 This conference led to a coalition of experts from virtual WHO mass gathering collaborating centres and global academic and public health faculty 5 to guide develop ment of, and update, optimal public health and medical prevention and treatment guidelines at mass gathering events. 6, 7 Mass gathering medicine as a new discipline was highlighted at the World Health Assembly of Ministers of Health in Geneva in May, 2014, where The Lancet Series on mass gathering medicine was launched. 7 These stateoftheart reviews covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health care providers from three mass gathering events: the London 2012 Summer Olympics and Paralympics, 8 the 2012 Union of European Football Associations European Championship finals, 9 and the Hajj pilgrimages of 2012 and 2013. 10 They set out the planning and surveillance systems used to monitor public health risks and described existing and potential public health threats (panel 2) and the experiences of healthcare providers.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MASS GATHERINGS AND PUBLIC HEALTH: CASE STUDIES FROM THE HAJJ TO MECCA\n",
      "----------------------------------------\n",
      "\n",
      "A mass gathering is defined by WHO as a planned or spontaneous event that gathers substantial numbers of attendees who might strain the health planning and response capacities of the host community, city, or country. 1 Mass gatherings can present important public health challenges related to the health of attendees and of the host country population and health services. 2 The concept of mass gathering medicine as a specialty emanated from discourse on the 2009 Hajj, which was held during the 2009 HIN1 influenza pandemic (panel 1). 3 The first International Conference on Mass Gatherings Medicine was held in Jeddah, Saudi Arabia, in October, 2010, where The Lancet Infectious Diseases Series on mass gatherings was launched (panel 1). 4 This conference led to a coalition of experts from virtual WHO mass gathering collaborating centres and global academic and public health faculty 5 to guide develop ment of, and update, optimal public health and medical prevention and treatment guidelines at mass gathering events. 6, 7 Mass gathering medicine as a new discipline was highlighted at the World Health Assembly of Ministers of Health in Geneva in May, 2014, where The Lancet Series on mass gathering medicine was launched. 7 These stateoftheart reviews covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health care providers from three mass gathering events: the London 2012 Summer Olympics and Paralympics, 8 the 2012 Union of European Football Associations European Championship finals, 9 and the Hajj pilgrimages of 2012 and 2013. 10 They set out the planning and surveillance systems used to monitor public health risks and described existing and potential public health threats (panel 2) and the experiences of healthcare providers.\n",
      "\n",
      "\n",
      "The World Health Organization describes a mass gathering as \"An organized or unplanned event where the number of people attending is sufficient to strain the planning and response resources of the community, state or nation hosting the event,\" whereas the US-based National Association of Emergency Medical Service Physicians defines it as \"Spectators and participants at events in which at least 1000 persons are gathered at a specific location for a defined period of time.\" 1 The Hajj, one of the world's largest mass gatherings, takes annually place in Mecca, Saudi Arabia. 2 In 2015, approximately 2.8 million Muslims from more than 183 countries visited this holy place for 5 days of rituals compulsory for all Muslims capable of undertaking the journey. 3 This challenge to the country perhaps is no less than organizing an Olympic every year. Saudi Arabia, being the custodian of the 2 holy cities (Mecca and Medina), provides extensive, multifaceted programs to serve these \"Guests of God.\" However, the annual event is confronted with public health challenges besides immigration, crowd, and crime management. In addition to the formidable logistics, the risk for spread of infectious diseases is well recognized in the era of globalization. Contemporary outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV), Ebola virus, and Zika virus have drawn much attention to global health. The annual Hajj event definitely calls for precautions. This paper is informed by a review of the literature and case studies among 2015 Hajj pilgrims.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MASS GATHERINGS HEALTH 6 RESEARCH AGENDA FOR MASS GATHERINGS: A CALL TO ACTION\n",
      "----------------------------------------\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n",
      "A mass gathering is defined by WHO as a planned or spontaneous event that gathers substantial numbers of attendees who might strain the health planning and response capacities of the host community, city, or country. 1 Mass gatherings can present important public health challenges related to the health of attendees and of the host country population and health services. 2 The concept of mass gathering medicine as a specialty emanated from discourse on the 2009 Hajj, which was held during the 2009 HIN1 influenza pandemic (panel 1). 3 The first International Conference on Mass Gatherings Medicine was held in Jeddah, Saudi Arabia, in October, 2010, where The Lancet Infectious Diseases Series on mass gatherings was launched (panel 1). 4 This conference led to a coalition of experts from virtual WHO mass gathering collaborating centres and global academic and public health faculty 5 to guide develop ment of, and update, optimal public health and medical prevention and treatment guidelines at mass gathering events. 6, 7 Mass gathering medicine as a new discipline was highlighted at the World Health Assembly of Ministers of Health in Geneva in May, 2014, where The Lancet Series on mass gathering medicine was launched. 7 These stateoftheart reviews covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health care providers from three mass gathering events: the London 2012 Summer Olympics and Paralympics, 8 the 2012 Union of European Football Associations European Championship finals, 9 and the Hajj pilgrimages of 2012 and 2013. 10 They set out the planning and surveillance systems used to monitor public health risks and described existing and potential public health threats (panel 2) and the experiences of healthcare providers.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CONSIDERATIONS FOR USE OF INVESTIGATIONAL DRUGS IN PUBLIC HEALTH EMERGENCIES\n",
      "----------------------------------------\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n",
      "A mass gathering is defined by WHO as a planned or spontaneous event that gathers substantial numbers of attendees who might strain the health planning and response capacities of the host community, city, or country. 1 Mass gatherings can present important public health challenges related to the health of attendees and of the host country population and health services. 2 The concept of mass gathering medicine as a specialty emanated from discourse on the 2009 Hajj, which was held during the 2009 HIN1 influenza pandemic (panel 1). 3 The first International Conference on Mass Gatherings Medicine was held in Jeddah, Saudi Arabia, in October, 2010, where The Lancet Infectious Diseases Series on mass gatherings was launched (panel 1). 4 This conference led to a coalition of experts from virtual WHO mass gathering collaborating centres and global academic and public health faculty 5 to guide develop ment of, and update, optimal public health and medical prevention and treatment guidelines at mass gathering events. 6, 7 Mass gathering medicine as a new discipline was highlighted at the World Health Assembly of Ministers of Health in Geneva in May, 2014, where The Lancet Series on mass gathering medicine was launched. 7 These stateoftheart reviews covered the planning and surveillance systems used to monitor public health risks, public health threats, and experiences of health care providers from three mass gathering events: the London 2012 Summer Olympics and Paralympics, 8 the 2012 Union of European Football Associations European Championship finals, 9 and the Hajj pilgrimages of 2012 and 2013. 10 They set out the planning and surveillance systems used to monitor public health risks and described existing and potential public health threats (panel 2) and the experiences of healthcare providers.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "MASS GATHERINGS HEALTH 1 EMERGENCE OF MEDICINE FOR MASS GATHERINGS: LESSONS FROM THE HAJJ\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "AN INTEGRATIVE APPROACH TO ENHANCING SMALL-SCALE POULTRY SLAUGHTERHOUSES BY ADDRESSING REGULATIONS AND FOOD SAFETY IN NORTHERN -THAILAND AN INTEGRATIVE APPROACH TO ENHANCING SMALL-SCALE POULTRY SLAUGHTERHOUSES BY ADDRESSING REGULATIONS AND FOOD SAFETY IN NORTHERN -THAILAND\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "COULD INFLUENZA TRANSMISSION BE REDUCED BY RESTRICTING MASS GATHERINGS? TOWARDS AN EVIDENCE-BASED POLICY FRAMEWORK\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "EFFECT OF NON-PHARMACEUTICAL INTERVENTIONS FOR CONTAINING THE COVID-19 OUTBREAK IN CHINA\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "INDICATIONS FOR HEALTHCARE SURGE CAPACITY IN EUROPEAN COUNTRIES FACING AN EXPONENTIAL INCREASE IN COVID19 CASES\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "MAKING DIFFICULT ETHICAL DECISIONS IN PATIENT CARE DURING NATURAL DISASTERS AND OTHER MASS CASUALTY EVENTS\n",
      "----------------------------------------\n",
      "\n",
      "Defi nitions of mass gatherings (MGs) vary greatly, with some sources specifying any gathering to be an MG when more than 1000 individuals attend, whereas others require the attendance of as many as 25 000 people to qualify. 1, 2 Irrespective of the defi nition, MGs represent large numbers of people attending an event that is focused at specifi c sites for a fi nite time. These gatherings might be planned or unplanned and recurrent or sporadic. Examples of MGs include World Youth Day, the summer and winter Olympics, rock concerts, and political rallies. MGs pose many challenges, such as crowd management, security, and emergency preparedness. Stampedes and crush injuries are common, the result of inevitable crowding. Outdoor events are associated with complications of exposure, dehydration, sunburn, and heat exhaustion. Other health hazards arise from lack of food hygiene, inadequate waste management, and poor sanitation. Violence is unpredictable and diffi cult to mitigate whether the MG is a political rally or a sporting competition. With few exceptions, however, the rates of morbidity and mortality resulting from these hazards are rarely increased outside the event. Global MGs, however, can lead to global hazards. Mitigation of risks requires expertise outside the specialty of acute care medicine, event planning, and venue engineering.\n",
      "\n",
      "\n",
      "A mass gathering (MG), as defi ned by WHO, is \"any occasion, either organized or spontaneous, that attracts suffi cient numbers of people to strain the planning and response resources of the community, city or nation hosting the event\". 1 MGs can be spontaneous or organised and include sports events, social or cultural functions, gatherings of displaced populations due to natural disasters or war, and political or religious congregations. [2] [3] [4] [5] Major MGs are likely to involve communities from diff erent parts of the world. Participants and host and home communities face health risks that are of international concern. Therefore, the control of infectious diseases and provision of medical services for non-communicable dis eases and other risks to health are increasingly important in the planning for MGs. Risks commonly associated with MGs include health systems having to accom modate a surge in capacity; challenges to existing health interventions; introduction and transmission of non-endemic diseases during and after MGs; diffi culties associated with risk communication to participants from diff erent cultures; and those arising because of the high profi le of some events, such as security risks.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 6\n",
    "tags ='pharmaceutical closures ban gatherings depending'\n",
    "show_relevant_articles(6, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 127,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "INTERNET-BASED SURVEILLANCE SYSTEMS FOR MONITORING EMERGING INFECTIOUS DISEASES\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SCIENCEDIRECT DEVELOPMENT OF THE ELECTRONIC SURVEILLANCE MONITORING SYSTEM ON WEB APPLICATIONS\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "To achieve the goal for the total health care, World Health Organization (WHO) suggests four health services: the continuum of care, the health promotion, the disease prevention, and the palliative care service. These services are the main key success factor for the concept of health for all and all for health. The concept of health for all basically covers the primary health care and universal health coverage 1 . The ideas for responsiveness, efficiency, accessibility and availability are included. On the other hand, the concept of all for health is focused on health literacy, social and financial risk. WHO experts also recommended the care takers to concentrate their additional efforts on surveillance reports and epidemiological surveys in the community level, before moving to the hospital process 2,3 . Both health promotion and the disease prevention require the multidisciplinary team, which combines staffs such as physicians, epidemiologists, nurses, and village head. Stakeholders from hospital levels and community levels must operate together to overcome the diseases under surveillance 4 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "BMC PUBLIC HEALTH BEYOND TRADITIONAL SURVEILLANCE: APPLYING SYNDROMIC SURVEILLANCE TO DEVELOPING SETTINGS -OPPORTUNITIES AND CHALLENGES\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "To achieve the goal for the total health care, World Health Organization (WHO) suggests four health services: the continuum of care, the health promotion, the disease prevention, and the palliative care service. These services are the main key success factor for the concept of health for all and all for health. The concept of health for all basically covers the primary health care and universal health coverage 1 . The ideas for responsiveness, efficiency, accessibility and availability are included. On the other hand, the concept of all for health is focused on health literacy, social and financial risk. WHO experts also recommended the care takers to concentrate their additional efforts on surveillance reports and epidemiological surveys in the community level, before moving to the hospital process 2,3 . Both health promotion and the disease prevention require the multidisciplinary team, which combines staffs such as physicians, epidemiologists, nurses, and village head. Stakeholders from hospital levels and community levels must operate together to overcome the diseases under surveillance 4 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "ADVANCED QUERYING FEATURES FOR DISEASE SURVEILLANCE SYSTEMS ADVANCED QUERYING FEATURES FOR DISEASE SURVEILLANCE SYSTEMS\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "To achieve the goal for the total health care, World Health Organization (WHO) suggests four health services: the continuum of care, the health promotion, the disease prevention, and the palliative care service. These services are the main key success factor for the concept of health for all and all for health. The concept of health for all basically covers the primary health care and universal health coverage 1 . The ideas for responsiveness, efficiency, accessibility and availability are included. On the other hand, the concept of all for health is focused on health literacy, social and financial risk. WHO experts also recommended the care takers to concentrate their additional efforts on surveillance reports and epidemiological surveys in the community level, before moving to the hospital process 2,3 . Both health promotion and the disease prevention require the multidisciplinary team, which combines staffs such as physicians, epidemiologists, nurses, and village head. Stakeholders from hospital levels and community levels must operate together to overcome the diseases under surveillance 4 .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "SMART HOME TECHNOLOGY FOR TELEMEDICINE AND EMERGENCY MANAGEMENT\n",
      "----------------------------------------\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "In the past decade, one of the fastest growing multidisciplinary research areas is telemedicine. Many definitions of this term exist depending on the specific context. Other terms that often used interchangeably, in conjunction with, or under the umbrella of telemedicine, include telehealthcare, telemonitoring, e-health, e-care, ambient assisted living, smart homecare etc. All these terminologies, though, have the same objectives of delivering remote healthcare to an individual's home and enabling continuous health monitoring and emergency management.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "EVALUATING HOSPITAL-BASED SURVEILLANCE FOR OUTBREAK DETECTION IN BANGLADESH: ANALYSIS OF HEALTHCARE UTILIZATION DATA\n",
      "----------------------------------------\n",
      "\n",
      "We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.\n",
      "\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "INTEGRATED SENSOR SYSTEMS AND DATA FUSION FOR HOMELAND PROTECTION\n",
      "----------------------------------------\n",
      "\n",
      "We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.\n",
      "\n",
      "\n",
      "Emerging infectious diseases are of particular concern to public health. Emergence is driven by sociocultural, environmental, and ecological factors. 1 The vulnerability of people to emerging infectious diseases has been shown by the emergence of AIDS in the late 1970s, severe acute respiratory syndrome (SARS) in 2003, pandemic infl uenza H1N1 in 2009, and multidrug-resistant nosocomial pathogens, as well as the re-emergence of dengue, chikungunya, and malaria. Traditionally, eff ective disease surveillance is expensive and needs a formal public health network. 2 Such systems are maintained by most countries, to varying degrees. Data sources, surveillance methods, analytical approaches, and factors aff ecting these systems are varied and have been reviewed in detail elsewhere. 3, 4 Traditional, passive surveillance systems typically rely on data submitted to the relevant public health authority by physicians, laboratories, and other health-care providers; they provide information crucial to the eff ective functioning of health systems. 5 These systems can be com plex and expensive. Time and resource constraints, as well as a lack of operational knowledge of reporting systems, adversely aff ect the completeness of reporting, 6 resulting in an incomplete account of disease emergence. Furthermore, substantial lags between an event and its notifi cation are common; a result of late or failed reporting and the hierarchical structure of these systems. 7 The average delay from receipt to dissemination of data by traditional sentinel surveillance networks is roughly 2 weeks. 8 Internet availability and use has increased greatly in the past 10 years (fi gure 1). 9, 10 The availability of healthrelated information on the internet (of varying quality and legitimacy) has also changed how people seek information about health. 10, 11 These changes provide a new means to detect and monitor infectious diseases. The nature of emerging infectious diseases often limits the eff ectiveness of traditional surveillance systems. 12 Digital surveillance could improve both the sensitivity and timeliness of detection of health events. 13 We review recent studies that have exploited internet use and search trends to monitor two acute-onset viral illnesses of worldwide importance that have substantial seasonal and geographic variation: infl uenza and dengue. We critically analyse the eff ectiveness of monitoring internet data to track these diseases and discuss the advantages and limitations of this approach. Finally, we make recommendations for future research into these systems.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "LEVERAGING THE LABORATORY RESPONSE NETWORK MODEL FOR THE GLOBAL HEALTH SECURITY AGENDA\n",
      "----------------------------------------\n",
      "\n",
      "I n recent years, considerable resources have been invested in improving laboratory systems in resourcelimited settings. Noticeable improvements in infrastructure and laboratory diagnostics can be observed in some but certainly not all of these settings. More coordination is needed to implement national laboratory plans, improve the quality of laboratory services, and expand surveillance for emerging infectious disease threats. In February 2014, the Obama Administration launched the Global Health Security Agenda (GHSA) with the aim of moving toward a world safe and secure from infectious disease threats. 1 Foundational to this agenda is the World Health Organization (WHO) Revised International Health Regulations (IHR) of 2005, which provide the legal framework for countries to strengthen their health systems in order to be able to respond to any public health emergency of international concern. The IHR goals are ''to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade.'' 2 The regulations call on countries to meet 8 core public health capacities, one of which is laboratory testing.\n",
      "\n",
      "\n",
      "We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.\n",
      "\n",
      "\n",
      "----------------------------------------\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "JAMIA FOCUS ON MEDIA-BASED BIOSURVEILLANCE MODEL FORMULATION  HEALTHMAP: GLOBAL INFECTIOUS DISEASE MONITORING THROUGH AUTOMATED CLASSIFICATION AND VISUALIZATION OF INTERNET MEDIA REPORTS\n",
      "----------------------------------------\n",
      "\n",
      "I n recent years, considerable resources have been invested in improving laboratory systems in resourcelimited settings. Noticeable improvements in infrastructure and laboratory diagnostics can be observed in some but certainly not all of these settings. More coordination is needed to implement national laboratory plans, improve the quality of laboratory services, and expand surveillance for emerging infectious disease threats. In February 2014, the Obama Administration launched the Global Health Security Agenda (GHSA) with the aim of moving toward a world safe and secure from infectious disease threats. 1 Foundational to this agenda is the World Health Organization (WHO) Revised International Health Regulations (IHR) of 2005, which provide the legal framework for countries to strengthen their health systems in order to be able to respond to any public health emergency of international concern. The IHR goals are ''to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade.'' 2 The regulations call on countries to meet 8 core public health capacities, one of which is laboratory testing.\n",
      "\n",
      "\n",
      "We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "APPLICATION OF NEXT GENERATION SEQUENCING TECHNOLOGY ON CONTAMINATION MONITORING IN MICROBIOLOGY LABORATORY\n",
      "----------------------------------------\n",
      "\n",
      "I n recent years, considerable resources have been invested in improving laboratory systems in resourcelimited settings. Noticeable improvements in infrastructure and laboratory diagnostics can be observed in some but certainly not all of these settings. More coordination is needed to implement national laboratory plans, improve the quality of laboratory services, and expand surveillance for emerging infectious disease threats. In February 2014, the Obama Administration launched the Global Health Security Agenda (GHSA) with the aim of moving toward a world safe and secure from infectious disease threats. 1 Foundational to this agenda is the World Health Organization (WHO) Revised International Health Regulations (IHR) of 2005, which provide the legal framework for countries to strengthen their health systems in order to be able to respond to any public health emergency of international concern. The IHR goals are ''to prevent, protect against, control and provide a public health response to the international spread of disease in ways that are commensurate with and restricted to public health risks, and which avoid unnecessary interference with international traffic and trade.'' 2 The regulations call on countries to meet 8 core public health capacities, one of which is laboratory testing.\n",
      "\n",
      "\n",
      "We propose a framework to evaluate the sensitivity and representativeness of hospital-based surveillance and apply it to severe neurological infectious diseases and fatal respiratory infectious diseases in Bangladesh. We identified cases in selected communities within surveillance hospital catchment areas using key informant and house-to-house surveys and ascertained where cases had sought care. We estimated the probability of surveillance detecting different sized outbreaks by distance from the surveillance hospital and compared characteristics of cases identified in the community and cases attending surveillance hospitals.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 7\n",
    "tags = \"diagnostics surveillance policy technology\"\n",
    "show_relevant_articles(7, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 128,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "PUBLIC PERCEPTION ON HEALTHCARE SERVICES: EVIDENCE FROM SOCIAL MEDIA PLATFORMS IN CHINA\n",
      "----------------------------------------\n",
      "\n",
      "Investigating public perception of healthcare services from different perspectives may generate inconsistent results. For example, patient-initiated violence against health workers [1] [2] [3] [4] [5] [6] , and the tension between doctors and patients for their dissatisfaction with the quality of healthcare [7, 8] , were wildly covered in the Chinese media. While patient experience surveys on the national level showed that patients were generally satisfied with both in-patient and out-patient services [9] . Such differences may result from biases rooted in the survey and media coverage; however, the inconsistency also pointed to the need for additional data sources to monitor public opinions on Chinese healthcare services.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "COLLABORATIVE ACCOUNTABILITY FOR SUSTAINABLE PUBLIC HEALTH: A KOREAN PERSPECTIVE ON THE EFFECTIVE USE OF ICT-BASED HEALTH RISK COMMUNICATION\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Investigating public perception of healthcare services from different perspectives may generate inconsistent results. For example, patient-initiated violence against health workers [1] [2] [3] [4] [5] [6] , and the tension between doctors and patients for their dissatisfaction with the quality of healthcare [7, 8] , were wildly covered in the Chinese media. While patient experience surveys on the national level showed that patients were generally satisfied with both in-patient and out-patient services [9] . Such differences may result from biases rooted in the survey and media coverage; however, the inconsistency also pointed to the need for additional data sources to monitor public opinions on Chinese healthcare services.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CRISIS COMMUNICATION IN CONTEXT: CULTURAL AND POLITICAL INFLUENCES UNDERPINNING CHINESE PUBLIC RELATIONS PRACTICE\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Much existing research analyzes the descriptive features of various crisis communication practices (e.g., Bradford and Garrett, 1995; Cancel, Cameron, Sallot, & Mitrook, 1997; Cho, 2005) and their effectiveness (Brown & White, 2010; Kim & Sung, 2014) . Though helpful, such research has been relatively inattentive to the contextual variables that determine specific practices, especially at the social, cultural, and cross-cultural levels. This has led to doubts about the applicability of crisis communicative strategies across cultures. Because Western cultural assumptions have shaped much research in the field of crisis communication, a revision of such assumptions is needed if the findings of public relations research in general (Pompper, 2005) and crisis communication in particular are to be more widely applicable. This paper addresses previous appeals for more culturally and contextually sensitive perspectives in crisis communication research (Avery, Lariscy, Kim, & Hocke, 2010) by investigating patterns of crisis communication as they have taken shape in three Chinese societies (Mainland China, Hong Kong, and Taiwan) . Along with Brazil, Russia, and India, China has one of the world's most rapidly developing markets. Its growing economy is creating new public relations opportunities within and outside its borders, thereby arousing worldwide interest in China's emergent engagement with the global economic sphere. In the first decade of the twenty-first century; however, China's economy faced several major crises. Some were explicitly economic, such as the Asian financial meltdown in 1998 and the WTO accession in 2001. Others affected the economy indirectly but with no less impact: bird flu outbreaks in 2001, SARS (Severe Acute Respiratory Syndrome) crises in 2003, the Wenchuan earthquake in 2008, and more recent food safety crises. Crisis management and crisis communication have therefore played a critical role in both the public and private sectors in contemporary China.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "IMPLEMENTING A ONE HEALTH APPROACH TO EMERGING INFECTIOUS DISEASE: REFLECTIONS ON THE SOCIO-POLITICAL, ETHICAL AND LEGAL DIMENSIONS\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Much existing research analyzes the descriptive features of various crisis communication practices (e.g., Bradford and Garrett, 1995; Cancel, Cameron, Sallot, & Mitrook, 1997; Cho, 2005) and their effectiveness (Brown & White, 2010; Kim & Sung, 2014) . Though helpful, such research has been relatively inattentive to the contextual variables that determine specific practices, especially at the social, cultural, and cross-cultural levels. This has led to doubts about the applicability of crisis communicative strategies across cultures. Because Western cultural assumptions have shaped much research in the field of crisis communication, a revision of such assumptions is needed if the findings of public relations research in general (Pompper, 2005) and crisis communication in particular are to be more widely applicable. This paper addresses previous appeals for more culturally and contextually sensitive perspectives in crisis communication research (Avery, Lariscy, Kim, & Hocke, 2010) by investigating patterns of crisis communication as they have taken shape in three Chinese societies (Mainland China, Hong Kong, and Taiwan) . Along with Brazil, Russia, and India, China has one of the world's most rapidly developing markets. Its growing economy is creating new public relations opportunities within and outside its borders, thereby arousing worldwide interest in China's emergent engagement with the global economic sphere. In the first decade of the twenty-first century; however, China's economy faced several major crises. Some were explicitly economic, such as the Asian financial meltdown in 1998 and the WTO accession in 2001. Others affected the economy indirectly but with no less impact: bird flu outbreaks in 2001, SARS (Severe Acute Respiratory Syndrome) crises in 2003, the Wenchuan earthquake in 2008, and more recent food safety crises. Crisis management and crisis communication have therefore played a critical role in both the public and private sectors in contemporary China.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "INFORMED PUBLIC AGAINST FALSE RUMOR IN THE SOCIAL MEDIA ERA: FOCUSING ON SOCIAL MEDIA DEPENDENCY\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Much existing research analyzes the descriptive features of various crisis communication practices (e.g., Bradford and Garrett, 1995; Cancel, Cameron, Sallot, & Mitrook, 1997; Cho, 2005) and their effectiveness (Brown & White, 2010; Kim & Sung, 2014) . Though helpful, such research has been relatively inattentive to the contextual variables that determine specific practices, especially at the social, cultural, and cross-cultural levels. This has led to doubts about the applicability of crisis communicative strategies across cultures. Because Western cultural assumptions have shaped much research in the field of crisis communication, a revision of such assumptions is needed if the findings of public relations research in general (Pompper, 2005) and crisis communication in particular are to be more widely applicable. This paper addresses previous appeals for more culturally and contextually sensitive perspectives in crisis communication research (Avery, Lariscy, Kim, & Hocke, 2010) by investigating patterns of crisis communication as they have taken shape in three Chinese societies (Mainland China, Hong Kong, and Taiwan) . Along with Brazil, Russia, and India, China has one of the world's most rapidly developing markets. Its growing economy is creating new public relations opportunities within and outside its borders, thereby arousing worldwide interest in China's emergent engagement with the global economic sphere. In the first decade of the twenty-first century; however, China's economy faced several major crises. Some were explicitly economic, such as the Asian financial meltdown in 1998 and the WTO accession in 2001. Others affected the economy indirectly but with no less impact: bird flu outbreaks in 2001, SARS (Severe Acute Respiratory Syndrome) crises in 2003, the Wenchuan earthquake in 2008, and more recent food safety crises. Crisis management and crisis communication have therefore played a critical role in both the public and private sectors in contemporary China.\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "SOCIAL DETERMINANTS OF HEALTH INEQUALITIES: TOWARDS A THEORETICAL PERSPECTIVE USING SYSTEMS SCIENCE\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Health outcomes are increasingly perceived from a systems approach that is more holistic and non-reductionist [1] . The author in a recent paper extended the systems approach to incorporate principles of complexity science and to conceptualize population health outcomes as an emergent property of a dynamic and open, complex adaptive system [2] . The current paper explores these themes further and applies the principles of systems approach and complexity science (i.e. systems science) to conceptualize social determinants of health inequalities (SDHI). The paper begins with a brief overview of the existing models of SDHI, and then proposes a two step approach to remodel our perspectives and outlines possible implications.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "BMC PUBLIC HEALTH IDENTIFYING STRATEGIES TO IMPROVE ACCESS TO CREDIBLE AND RELEVANT INFORMATION FOR PUBLIC HEALTH PROFESSIONALS: A QUALITATIVE STUDY\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Health outcomes are increasingly perceived from a systems approach that is more holistic and non-reductionist [1] . The author in a recent paper extended the systems approach to incorporate principles of complexity science and to conceptualize population health outcomes as an emergent property of a dynamic and open, complex adaptive system [2] . The current paper explores these themes further and applies the principles of systems approach and complexity science (i.e. systems science) to conceptualize social determinants of health inequalities (SDHI). The paper begins with a brief overview of the existing models of SDHI, and then proposes a two step approach to remodel our perspectives and outlines possible implications.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "UNRAVELING THE COMPLEXITIES OF DISASTER MANAGEMENT: A FRAMEWORK FOR CRITICAL SOCIAL INFRASTRUCTURE TO PROMOTE POPULATION HEALTH AND RESILIENCE\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Health outcomes are increasingly perceived from a systems approach that is more holistic and non-reductionist [1] . The author in a recent paper extended the systems approach to incorporate principles of complexity science and to conceptualize population health outcomes as an emergent property of a dynamic and open, complex adaptive system [2] . The current paper explores these themes further and applies the principles of systems approach and complexity science (i.e. systems science) to conceptualize social determinants of health inequalities (SDHI). The paper begins with a brief overview of the existing models of SDHI, and then proposes a two step approach to remodel our perspectives and outlines possible implications.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "RISK MANAGEMENT AND HEALTHCARE POLICY DOVEPRESS CRITICAL ROLE OF ETHICS IN CLINICAL MANAGEMENT AND PUBLIC HEALTH RESPONSE TO THE WEST AFRICA EBOLA EPIDEMIC\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Health outcomes are increasingly perceived from a systems approach that is more holistic and non-reductionist [1] . The author in a recent paper extended the systems approach to incorporate principles of complexity science and to conceptualize population health outcomes as an emergent property of a dynamic and open, complex adaptive system [2] . The current paper explores these themes further and applies the principles of systems approach and complexity science (i.e. systems science) to conceptualize social determinants of health inequalities (SDHI). The paper begins with a brief overview of the existing models of SDHI, and then proposes a two step approach to remodel our perspectives and outlines possible implications.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "RISK COMMUNICATION AND MANAGEMENT IN PUBLIC HEALTH CRISES\n",
      "----------------------------------------\n",
      "\n",
      "The sustainability of public health practices requires collaboration between the government and its citizens. On the government's side, social media can provide a conduit for communicating health risk information in an effective and timely fashion, while also engaging citizens in informed decision-making. On the citizen's side, information communication technology (ICT)-based practices cannot function unless citizens recognize and act on their responsibility to actively engage with government social media platforms. Despite an increasing interest in understanding the adoption of ICT practices and e-government services for health risk communication, there remains a crucial need for a comprehensive framework to explain which factors determine citizen use of digital government resources. The purpose of this study is to investigate how to increase government accountability for motivating citizens to engage in ICT-based health risk communication, thereby attaining sustainable public health practices through collaborative governance.\n",
      "\n",
      "\n",
      "Health outcomes are increasingly perceived from a systems approach that is more holistic and non-reductionist [1] . The author in a recent paper extended the systems approach to incorporate principles of complexity science and to conceptualize population health outcomes as an emergent property of a dynamic and open, complex adaptive system [2] . The current paper explores these themes further and applies the principles of systems approach and complexity science (i.e. systems science) to conceptualize social determinants of health inequalities (SDHI). The paper begins with a brief overview of the existing models of SDHI, and then proposes a two step approach to remodel our perspectives and outlines possible implications.\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# TASK 9\n",
    "tags = \"ethical social education access fear\"\n",
    "show_relevant_articles(9, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 130,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "THE INTERNATIONAL HEALTH REGULATIONS: THE GOVERNING FRAMEWORK FOR GLOBAL HEALTH SECURITY\n",
      "----------------------------------------\n",
      "\n",
      "The IHR's origins can be traced to a series of Sanitary Conferences beginning in 1851 to forge an international agreement to curb the spread of infectious diseases (originally cholera, followed by plague and yellow fever) entering Europe from Asia, particularly India and the Levant. 10 At that time, the concept of global health security meant protecting Europe without unduly hindering trade. The Sanitary Conferences led to a binding agreement in 1892-the International Sanitary Convention (ISC)-focused on quarantine for cholera. European states subsequently adopted additional conventions, which were incorporated into a single ISC. By 1926, the ISC covered primarily cholera, yellow fever, and plague. The raison d'tre of the earliest treaties grew out of a perceived security imperative for powerful countries. Most important was selfprotection against external threats, rather than safeguarding the public's health in every region of the world.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "GLOBAL HEALTH AND FOREIGN POLICY\n",
      "----------------------------------------\n",
      "\n",
      "Global health issues have long been a concern for foreignpolicy-makers. From sanitary cordons instituted to prevent plague from entering Croatia's Dalmatian Coast to the international sanitary conventions, which began in 1851, to the victories over malaria and yellow fever that permitted the construction of the strategic Panama Canal, health and disease have been intertwined with the pursuit of foreignpolicy interests. However, over the last 2 decades, globalization has made global health more relevant across multiple aspects of foreign policy than ever before. Fidler calls this a ''revolution'' in the political status of global health, noting that ''nothing in the prior history of national and international efforts on public health compares to the political status public health has reached today'' (1, p. 45) .\n",
      "\n",
      "\n",
      "The IHR's origins can be traced to a series of Sanitary Conferences beginning in 1851 to forge an international agreement to curb the spread of infectious diseases (originally cholera, followed by plague and yellow fever) entering Europe from Asia, particularly India and the Levant. 10 At that time, the concept of global health security meant protecting Europe without unduly hindering trade. The Sanitary Conferences led to a binding agreement in 1892-the International Sanitary Convention (ISC)-focused on quarantine for cholera. European states subsequently adopted additional conventions, which were incorporated into a single ISC. By 1926, the ISC covered primarily cholera, yellow fever, and plague. The raison d'tre of the earliest treaties grew out of a perceived security imperative for powerful countries. Most important was selfprotection against external threats, rather than safeguarding the public's health in every region of the world.\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "CAPACITY OF PUBLIC HEALTH SURVEILLANCE TO COMPLY WITH REVISED INTERNATIONAL HEALTH REGULATIONS, USA AUTHOR AFFI LIATIONS: CENTERS FOR DISEASE CONTROL AND PREVENTION\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "Global health issues have long been a concern for foreignpolicy-makers. From sanitary cordons instituted to prevent plague from entering Croatia's Dalmatian Coast to the international sanitary conventions, which began in 1851, to the victories over malaria and yellow fever that permitted the construction of the strategic Panama Canal, health and disease have been intertwined with the pursuit of foreignpolicy interests. However, over the last 2 decades, globalization has made global health more relevant across multiple aspects of foreign policy than ever before. Fidler calls this a ''revolution'' in the political status of global health, noting that ''nothing in the prior history of national and international efforts on public health compares to the political status public health has reached today'' (1, p. 45) .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "HEALTH SECURITY CAPACITIES IN THE CONTEXT OF COVID-19 OUTBREAK: AN ANALYSIS OF INTERNATIONAL HEALTH REGULATIONS ANNUAL REPORT DATA FROM 182 COUNTRIES\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "Global health issues have long been a concern for foreignpolicy-makers. From sanitary cordons instituted to prevent plague from entering Croatia's Dalmatian Coast to the international sanitary conventions, which began in 1851, to the victories over malaria and yellow fever that permitted the construction of the strategic Panama Canal, health and disease have been intertwined with the pursuit of foreignpolicy interests. However, over the last 2 decades, globalization has made global health more relevant across multiple aspects of foreign policy than ever before. Fidler calls this a ''revolution'' in the political status of global health, noting that ''nothing in the prior history of national and international efforts on public health compares to the political status public health has reached today'' (1, p. 45) .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "INVESTIGATING PUBLIC HEALTH EMERGENCY RESPONSE INFORMATION SYSTEM INITIATIVES IN CHINA\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "Global health issues have long been a concern for foreignpolicy-makers. From sanitary cordons instituted to prevent plague from entering Croatia's Dalmatian Coast to the international sanitary conventions, which began in 1851, to the victories over malaria and yellow fever that permitted the construction of the strategic Panama Canal, health and disease have been intertwined with the pursuit of foreignpolicy interests. However, over the last 2 decades, globalization has made global health more relevant across multiple aspects of foreign policy than ever before. Fidler calls this a ''revolution'' in the political status of global health, noting that ''nothing in the prior history of national and international efforts on public health compares to the political status public health has reached today'' (1, p. 45) .\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "PANDEMIC H1N1 IN CANADA AND THE USE OF EVIDENCE IN DEVELOPING PUBLIC HEALTH POLICIES E A POLICY ANALYSIS\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "Global health issues have long been a concern for foreignpolicy-makers. From sanitary cordons instituted to prevent plague from entering Croatia's Dalmatian Coast to the international sanitary conventions, which began in 1851, to the victories over malaria and yellow fever that permitted the construction of the strategic Panama Canal, health and disease have been intertwined with the pursuit of foreignpolicy interests. However, over the last 2 decades, globalization has made global health more relevant across multiple aspects of foreign policy than ever before. Fidler calls this a ''revolution'' in the political status of global health, noting that ''nothing in the prior history of national and international efforts on public health compares to the political status public health has reached today'' (1, p. 45) .\n",
      "\n",
      "\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "----------------------------------------\n",
      "PUBLIC HEALTH HUMAN RESOURCES: A COMPARATIVE ANALYSIS OF POLICY DOCUMENTS IN TWO CANADIAN PROVINCES\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "The increase in communicable and non-communicable disease incidence and prevalence, changing population demographics, along with concerns about pandemics, natural disasters, and terrorism, have highlighted the challenges faced by public health systems to respond rapidly and appropriately to threats [1, 2] . Governments, recognizing the importance of public health to address these threats, have focused on strengthening public health systems in many countries including Canada [3] , the United States [2] and across Europe [4] . A key factor in rebuilding and sustaining public health is a robust public health workforce. Improved public health human resources (PHHR) policy, planning, and management have been identified as priorities in international reports [3, 5] . In separate national public health priority setting consultations, both Canada and the United States have identified issues related to the public health workforce as priorities [6, 7] . Indeed '(no) attempt to improve public health will succeed that does not recognize the fundamental importance of providing and maintaining in every local health agency across Canada an adequate staff of highly skilled and motivated public health professionals' [3] (p. 136).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "BMC PUBLIC HEALTH ESTABLISHING A NATIONWIDE EMERGENCY DEPARTMENT-BASED SYNDROMIC SURVEILLANCE SYSTEM FOR BETTER PUBLIC HEALTH RESPONSES IN TAIWAN\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "The increase in communicable and non-communicable disease incidence and prevalence, changing population demographics, along with concerns about pandemics, natural disasters, and terrorism, have highlighted the challenges faced by public health systems to respond rapidly and appropriately to threats [1, 2] . Governments, recognizing the importance of public health to address these threats, have focused on strengthening public health systems in many countries including Canada [3] , the United States [2] and across Europe [4] . A key factor in rebuilding and sustaining public health is a robust public health workforce. Improved public health human resources (PHHR) policy, planning, and management have been identified as priorities in international reports [3, 5] . In separate national public health priority setting consultations, both Canada and the United States have identified issues related to the public health workforce as priorities [6, 7] . Indeed '(no) attempt to improve public health will succeed that does not recognize the fundamental importance of providing and maintaining in every local health agency across Canada an adequate staff of highly skilled and motivated public health professionals' [3] (p. 136).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "STEPS TO A SUSTAINABLE PUBLIC HEALTH SURVEILLANCE ENTERPRISE STEPS TO A SUSTAINABLE PUBLIC HEALTH SURVEILLANCE ENTERPRISE A COMMENTARY FROM THE INTERNATIONAL SOCIETY FOR DISEASE SURVEILLANCE STEPS TO A SUSTAINABLE PUBLIC HEALTH SURVEILLANCE ENTERPRISE OJPHI\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "The increase in communicable and non-communicable disease incidence and prevalence, changing population demographics, along with concerns about pandemics, natural disasters, and terrorism, have highlighted the challenges faced by public health systems to respond rapidly and appropriately to threats [1, 2] . Governments, recognizing the importance of public health to address these threats, have focused on strengthening public health systems in many countries including Canada [3] , the United States [2] and across Europe [4] . A key factor in rebuilding and sustaining public health is a robust public health workforce. Improved public health human resources (PHHR) policy, planning, and management have been identified as priorities in international reports [3, 5] . In separate national public health priority setting consultations, both Canada and the United States have identified issues related to the public health workforce as priorities [6, 7] . Indeed '(no) attempt to improve public health will succeed that does not recognize the fundamental importance of providing and maintaining in every local health agency across Canada an adequate staff of highly skilled and motivated public health professionals' [3] (p. 136).\n",
      "\n",
      "\n",
      "----------------------------------------\n",
      "PANDEMIC PLANNING IN PEDIATRIC CARE: A WEBSITE POLICY REVIEW AND NATIONAL SURVEY DATA\n",
      "----------------------------------------\n",
      "\n",
      "T he 2005 revisions to the International Health Regulations (IHR 2005) were a major global policy achievement to ensure international recognition and notifi cation of unusual public health events. These regulations are an international legal instrument that binds 194 countries (World Health Organization [WHO] member states). The goal of IHR 2005 is to help the international community prevent or respond to acute public health risks that have the potential to cross borders and threaten the global population. As seen with the emergence of pandemic (H1N1) 2009, diseases have the potential to spread quickly around the globe through international travel and trade (1) . Member states are required to report certain diseases and public health events to WHO. Furthermore, the rights and obligations of member states are defi ned to establish procedures that WHO must follow to uphold global public health security (2) .\n",
      "\n",
      "\n",
      "The increase in communicable and non-communicable disease incidence and prevalence, changing population demographics, along with concerns about pandemics, natural disasters, and terrorism, have highlighted the challenges faced by public health systems to respond rapidly and appropriately to threats [1, 2] . Governments, recognizing the importance of public health to address these threats, have focused on strengthening public health systems in many countries including Canada [3] , the United States [2] and across Europe [4] . A key factor in rebuilding and sustaining public health is a robust public health workforce. Improved public health human resources (PHHR) policy, planning, and management have been identified as priorities in international reports [3, 5] . In separate national public health priority setting consultations, both Canada and the United States have identified issues related to the public health workforce as priorities [6, 7] . Indeed '(no) attempt to improve public health will succeed that does not recognize the fundamental importance of providing and maintaining in every local health agency across Canada an adequate staff of highly skilled and motivated public health professionals' [3] (p. 136).\n",
      "\n",
      "\n"
     ]
    }
   ],
   "source": [
    "# task 10\n",
    "tags = 'government published surveillance policy'\n",
    "show_relevant_articles(10, tags)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
